Cancer Medicines Forum: December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 December 2025, 16:00 (CET) to 2 December 2025, 17:00 (CET)

Submitted by Anonymous (not verified) on 25 February 2026 - 9:44

Cancer Medicines Forum: December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 December 2025, 16:00 (CET) to 2 December 2025, 17:00 (CET)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 January 2026, 13:30 (CET) to 30 January 2026, 15:30 (CET)

Submitted by Anonymous (not verified) on 25 February 2026 - 8:09

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 January 2026, 13:30 (CET) to 30 January 2026, 15:30 (CET)

Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 24 February 2026 - 16:12

Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 24 February 2026 - 16:00

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness